Titan Pharmaceuticals
TTNP
#10925
Rank
HK$48.07 M
Marketcap
HK$36.14
Share price
-3.76%
Change (1 day)
16.75%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -HK$34.26

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -HK$34.41. In 2023 the company made an earnings per share (EPS) of -HK$58.09 an increase over its 2022 EPS that were of -HK$119.08.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$34.26
2023-HK$58.09-51.22%
2022-HK$119.08-15.61%
2021-HK$141.10-81.37%
2020-HK$757.26-77.52%
2019-HK$3,369-56.32%
2018-HK$7,714-59.51%
2017-HK$19,053-371.81%
2016HK$7,010-144.35%
2015-HK$15,804300%
2014-HK$3,951-121.54%
2013HK$18,344-151.38%
2012-HK$35,700-11.54%
2011-HK$40,356188.89%
2010-HK$13,969-10%
2009-HK$15,522
2007-HK$63,638-2.38%
2006-HK$65,191-39.13%
2005-HK$107,099-16.87%
2004-HK$128,829-22.43%
2003-HK$166,0814.9%
2002-HK$158,32061.9%
2001-HK$97,786-13.7%
2000-HK$113,30765.01%
1999-HK$68,668-35.87%
1998-HK$107,080-1824.71%
1997HK$6,209-102.4%
1996-HK$259,210

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.47-298.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$55.03-259.91%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-HK$31.75-7.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
HK$7.21-120.96%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-HK$1.88-94.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$33.39-2.96%๐Ÿ‡บ๐Ÿ‡ธ USA